External validation of models to predict hepatocellular carcinoma in Hepatitis C Virus cured F3-F4 patients.

Ângela Carvalho-GomesTsveta Vladi Valcheva ValchevaIván SahucoEnrique VidalLaura Martínez-ArenasCarmen VinaixaVictoria AguileraSónia García GarcíaMarina C Berenguer

Published in: United European gastroenterology journal (2024)

In our cohort, the Alonso A model allows the most reliable reduction in HCC screening resulting in safely stopping life-long monitoring in about a third of F3-F4 patients achieving SVR with DAAs.

Keyphrases

end stage renal disease
hepatitis c virus
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
human immunodeficiency virus
antiretroviral therapy